CLARKSVILLE, Md., Oct. 9, 2012 (SEND2PRESS NEWSWIRE) -- iFOS, as an emerging leader in Federal financial solutions and technology, announced that the firm was awarded an Indefinite Delivery, Indefinite Quantity (IDIQ) base plus 4 option years contract award to support CDFI grant programs. This effort will require iFOS to recruit up to 100 field reviewers that can evaluate CDFI grant applications submitted from start-up organizations as well as large, national scale enterprises.
The project involves managing subject-matter expertise in community development finance and community development tax credit programs, including expertise in different types of financial institutions (i.e. loan funds, community development entities, credit unions, banks, and venture capital funds) and different types of community development activities (i.e., affordable housing development, commercial real estate development, community facilities development, charter school development, community health facilities, small business lending, etc.).
"Breaking through several fiscal challenges faced by the CDFI requires an innovative firm as iFOS with the unique expertise and advanced communications infrastructure required to administer fairness and equity in the grants application process. iFOS is honored to provide the required services and looks forward to taking CDFI grants to the next level in public funding over the coming years," said Tawanda Smith, President and CEO of iFOS.
About Intelligent Fiscal Optimal Solutions (iFOS)(R), LLC:
iFOS Managing Consultants, LLC is a 8(a) certified, woman-owned small business of staff augmentation, management consulting and training. The firm provides specialized services in Federal Financial Management, Grants Management Support, Forensic Accounting, Acquisition and Contracts Management, and IT Portfolio Management Services.
The company is headquartered in Clarksville, Maryland. For more information, visit: http://www.ifoscorp.com.
For more information regarding this press release, please visit:
Rights granted for reproduction by any legitimate news organization. However, if news is cloned/scraped verbatim, then original attribution must be maintained with link back to this page as “original syndication source.” Resale of this content for commercial purposes is prohibited without a license. Reproduction on any site selling a competitive service is also prohibited. Information is believed accurate, as provided by news source or authorized agency, however is not guaranteed, and you assume all risk for use of any information found herein/hereupon. This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License.
4256 times (1 today, 4 this week, 1 this month, 805 this year)